NCT00004026 - CT-2584 in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Previous Therapy | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

December 31, 1998

Primary Completion Date

January 31, 2005

Study Completion Date

January 31, 2005

Conditions

Prostate Cancer

Interventions

DRUG

CT-2584

DRUG

chemotherapy

Trial Locations (7)

Herbert Irving Comprehensive Cancer Center, New York

Our Lady of Mercy Medical Center, The Bronx

Johns Hopkins Oncology Center, Baltimore

Stanley Scott Cancer Center, New Orleans

Jonsson Comprehensive Cancer Center, UCLA, Los Angeles

UCSF Cancer Center and Cancer Research Institute, San Francisco

University of Washington Medical Center, Seattle